Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 2/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17246970 | 0.91 | ALDH1A1 (0.37) | NQO2NQO1ALOX5PTPN1ALDH1A1 | |
| SCHEMBL17247023 | 0.90 | NQO2 (0.36) | NQO2NQO1ALOX5KDM4EMEN1 | |
| SCHEMBL17247138 | 0.90 | CYP1A1 (0.36) | NQO2NQO1ALOX5KDM4EMEN1 | |
| SCHEMBL20374947 | 0.89 | NQO2 (0.32) | NQO2NQO1ALOX5ALDH1A1CYP1A2 | |
| SCHEMBL17246971 | 0.88 | ALDH1A1 (0.38) | NQO2NQO1ALOX5MEN1KMT2A | |
| SCHEMBL17246972 | 0.87 | ALOX5 (0.40) | ALOX5PTPN1ALDH1A1CYP1A2THRB | |
| SCHEMBL20053379 | 0.86 | ERBB2 (0.32) | ALOX5ALDH1A1CYP1A2HPGDHSD17B10 | |
| SCHEMBL17246976 | 0.86 | HPRT1 (0.38) | NQO2NQO1ALOX5MEN1KMT2A | |
| SCHEMBL17246986 | 0.85 | ALOX5 (0.37) | ALOX5MEN1KMT2APTPN1CYP1A2 | |
| SCHEMBL17246969 | 0.85 | CYP1A2 (0.34) | NQO2NQO1ALOX5KDM4EPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | NQO2 2373/4885NQO1 995/4885ALOX5 4115/4885 |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | NQO2 1856/4885NQO1 244/4885ALOX5 1507/4885 |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | NQO2 1856/4885NQO1 244/4885ALOX5 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.